Multi Hanna Kreasindo Tbk. (MHKI.JK)
IDR 121.0
(6.14%)
IDR 121.0
(6.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 148.33 Billion | 132.19 Billion | 97.04 Billion | 61.31 Billion |
| Cost of Revenue | 70.56 Billion | 71.7 Billion | 66.93 Billion | 42.08 Billion |
| Gross Profit | 77.77 Billion | 60.48 Billion | 30.1 Billion | 19.22 Billion |
| Operating Expenses | 41.19 Billion | 21.93 Billion | 18.07 Billion | 15.02 Billion |
| Selling, General and Administrative Expenses | 26.25 Billion | 23.03 Billion | 18.08 Billion | 15.45 Billion |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | 14.94 Billion | - | - | - |
| Cost and Expenses | 111.75 Billion | 93.64 Billion | 85 Billion | 57.11 Billion |
| Operating Income | 36.57 Billion | 37.08 Billion | 11.95 Billion | 3.6 Billion |
| Interest Expense | - | - | - | - |
| Income Tax Expense | 21.5 Billion | 8.73 Billion | 2.84 Billion | 1.35 Billion |
| Earnings before Tax | 50.21 Billion | 38.56 Billion | 11.96 Billion | 4.12 Billion |
| Net Income | 28.7 Billion | 29.82 Billion | 9.11 Billion | 2.77 Billion |
| Earnings Per Share Basic | 9.57 | 9.94 | 3.04 | 0.92 |
| Earnings Per Share Diluted | 9.57 | 9.94 | 3.04 | 0.92 |
| Weighted Average Shares Outstanding | 3 Billion | 3 Billion | 3 Billion | 3 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3 Billion | 3 Billion | 3 Billion | 3 Billion |
| Gross Margin | 0.52 | 0.46 | 0.31 | 0.31 |
| EBIT Margin | 0.43 | 0.34 | 0.20 | 0.15 |
| Profit Margin | 0.19 | 0.23 | 0.09 | 0.05 |
| EBITDA | 63.82 Billion | 44.43 Billion | 19.07 Billion | 9.27 Billion |
| Earnings Before Tax Margin | 0.25 | 0.28 | 0.12 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 38.94 Billion | 38.94 Billion | 40.33 Billion | 148.33 Billion | 34.87 Billion | 34.87 Billion |
| Cost of Revenue | 19.28 Billion | 19.28 Billion | 25.69 Billion | 70.56 Billion | 12.79 Billion | 12.79 Billion |
| Gross Profit | 19.66 Billion | 19.66 Billion | 14.63 Billion | 77.77 Billion | 22.08 Billion | 22.08 Billion |
| Operating Expenses | 11.02 Billion | 10.91 Billion | 8.03 Billion | 28.06 Billion | 6.05 Billion | 6.05 Billion |
| Selling, General and Administrative Expenses | 10.96 Billion | 10.96 Billion | 6.51 Billion | - | 5.89 Billion | 5.89 Billion |
| Research and Development Expenses | 312.04 Million | 312.04 Million | - | - | 187.5 Million | 187.5 Million |
| Other Expenses | -248.79 Million | - | - | - | - | - |
| Cost and Expenses | 30.3 Billion | 30.19 Billion | 33.73 Billion | 98.62 Billion | 18.84 Billion | 18.84 Billion |
| Operating Income | 8.63 Billion | 8.66 Billion | 6.79 Billion | 49.88 Billion | 16.18 Billion | 16.18 Billion |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.91 Billion | 1.91 Billion | 1.37 Billion | 21.5 Billion | 3.62 Billion | 3.62 Billion |
| Earnings before Tax | 8.81 Billion | 8.81 Billion | 6.82 Billion | 50.21 Billion | 16.11 Billion | 16.11 Billion |
| Net Income | 6.9 Billion | 6.9 Billion | 5.45 Billion | 28.7 Billion | 12.49 Billion | 12.49 Billion |
| Earnings Per Share Basic | 1.84 | 1.84 | 1.82 | - | 4.16 | 4.16 |
| Earnings Per Share Diluted | 1.84 | 1.84 | 1.82 | - | 4.16 | 4.16 |
| Weighted Average Shares Outstanding | 3.75 Billion | 3.75 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.75 Billion | 3.75 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion |
| Gross Margin | 0.50 | 0.50 | 0.36 | 0.52 | 0.63 | 0.63 |
| EBIT Margin | 0.29 | 0.29 | 0.38 | - | 0.66 | 0.66 |
| Profit Margin | 0.18 | 0.18 | 0.14 | 0.19 | 0.36 | 0.36 |
| EBITDA | 11.47 Billion | 11.47 Billion | 15.25 Billion | - | 23.15 Billion | 23.15 Billion |
| Earnings Before Tax Margin | 0.22 | 0.22 | 0.17 | 0.34 | 0.46 | 0.46 |
605128
0177
C6L
PPLPHARMA
ATAP
CBSM